Clinical Trial: TBE Zone 2 PMS in Japan

U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07049913) titled 'TBE Zone 2 PMS in Japan' on June 25.

Brief Summary: The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.

Study Start Date: Sept., 2025

Study Type: OBSERVATIONAL

Condition: Aneurysm Thoracic Dissection of Aorta, Thoracic Trauma

Intervention: DEVICE: Gore(R) TAG(R) Thoracic Aortic Branch Stent Graft System

Patients who attempted implant of TBE in Zone 2 during the enrollment period of this surveillance.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: W.L.Gore & Associates

Published by HT Digital Content Services with ...